Mark F Brady has not added Biography.
If you are Mark F Brady and would like to personalize this page please email our Author Liaison for assistance.
Pilot evaluation of high-dose carboplatin and paclitaxel followed by high-dose melphalan supported by peripheral blood stem cells in previously untreated advanced ovarian cancer: a gynecologic oncology group study.
Gynecologic oncology Jan, 2003 | Pubmed ID: 12504619
Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma-a Gynecologic Oncology Group Study.
Gynecologic oncology Apr, 2003 | Pubmed ID: 12694669
Phase III trial of paclitaxel at two dose levels, the higher dose accompanied by filgrastim at two dose levels in platinum-pretreated epithelial ovarian cancer: an intergroup study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Aug, 2003 | Pubmed ID: 12807937
Adjuvant treatment for early ovarian cancer: a randomized phase III trial of intraperitoneal 32P or intravenous cyclophosphamide and cisplatin--a gynecologic oncology group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Dec, 2003 | Pubmed ID: 14645424
Analysis of CHEK2 gene for ovarian cancer susceptibility.
Gynecologic oncology Oct, 2004 | Pubmed ID: 15385111
Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Oct, 2004 | Pubmed ID: 15459211
Secondary surgical cytoreduction for advanced ovarian carcinoma.
The New England journal of medicine Dec, 2004 | Pubmed ID: 15590951
Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study.
Gynecologic oncology Sep, 2006 | Pubmed ID: 16860852
Intraperitoneal therapy for ovarian cancer: a treatment ready for prime time.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Oct, 2006 | Pubmed ID: 17008690
Effects of initial graft tension on the tibiofemoral compressive forces and joint position after anterior cruciate ligament reconstruction.
The American journal of sports medicine Mar, 2007 | Pubmed ID: 17218659
Directly observed highly active antiretroviral therapy for HIV-infected children in Cambodia.
American journal of public health Jun, 2007 | Pubmed ID: 17463375
A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus.
Gynecologic oncology Nov, 2007 | Pubmed ID: 17822748
Phase III randomized trial of intravenous cisplatin plus a 24- or 96-hour infusion of paclitaxel in epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Oct, 2007 | Pubmed ID: 17906207
Corticosteroids reduce postoperative morbidity after third molar surgery: a systematic review and meta-analysis.
Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons Sep, 2008 | Pubmed ID: 18718396
Tibiofemoral compression force differences using laxity- and force-based initial graft tensioning techniques in the anterior cruciate ligament-reconstructed cadaveric knee.
Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association Sep, 2008 | Pubmed ID: 18760214
Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Mar, 2009 | Pubmed ID: 19224846
Congenital Trypanosoma cruzi transmission in Santa Cruz, Bolivia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Dec, 2009 | Pubmed ID: 19877966
Microscopic observation drug susceptibility assay for tuberculosis screening before isoniazid preventive therapy in HIV-infected persons.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Apr, 2010 | Pubmed ID: 20192727
Prognostic relevance of uncommon ovarian histology in women with stage III/IV epithelial ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society Aug, 2010 | Pubmed ID: 20683400
Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evaluation of serum vascular endothelial growth factor (VEGF): A Gynecologic Oncology Group Study.
Gynecologic oncology Dec, 2010 | Pubmed ID: 20846715
Advanced stage mucinous adenocarcinoma of the ovary is both rare and highly lethal: a Gynecologic Oncology Group study.
Cancer Feb, 2011 | Pubmed ID: 20862744
EORTC 55971: does it apply to all patients with advanced state ovarian cancer?
Gynecologic oncology Feb, 2011 | Pubmed ID: 21093893
Improved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations.
Gynecologic oncology May, 2011 | Pubmed ID: 21276604
Nuclear P27 expression in benign, borderline (LMP) and invasive tumors of the ovary and its association with prognosis: a gynecologic oncology group study.
Gynecologic oncology May, 2011 | Pubmed ID: 21310472
A randomized phase III trial of IV carboplatin and paclitaxel × 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-stage ovarian carcinoma: a Gynecologic Oncology Group Study.
Gynecologic oncology Jul, 2011 | Pubmed ID: 21529904
CA125 regression in ovarian cancer patients treated with intravenous versus intraperitoneal platinum-based chemotherapy: A gynecologic oncology group study.
Gynecologic oncology Feb, 2012 | Pubmed ID: 22033034
Incorporation of bevacizumab in the primary treatment of ovarian cancer.
The New England journal of medicine Dec, 2011 | Pubmed ID: 22204724
1, The Warren Alpert Medical School of Brown University,
2Laboratorio de Investigacion de Enfermedades Infecciosas, Universidad Peruana Cayetano Heredia,
3Department of International Health, Johns Hopkins Bloomberg School of Public Health,
4Wellcome Trust Centre for Clinical Tropical Medicine, Imperial College London
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados